These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33614893)

  • 1. Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective study.
    Bucholc M; McClean PL; Bauermeister S; Todd S; Ding X; Ye Q; Wang D; Huang W; Maguire LP
    Alzheimers Dement (N Y); 2021; 7(1):e12122. PubMed ID: 33614893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hearing impairment and hearing aid use on progression to mild cognitive impairment in cognitively healthy adults: An observational cohort study.
    Bucholc M; Bauermeister S; Kaur D; McClean PL; Todd S
    Alzheimers Dement (N Y); 2022; 8(1):e12248. PubMed ID: 35229022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Persson K; Barca ML; Eldholm RS; Cavallin L; Šaltytė Benth J; Selbæk G; Brækhus A; Saltvedt I; Engedal K
    Dement Geriatr Cogn Disord; 2017; 44(1-2):12-24. PubMed ID: 28614836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification, Prediction, and Concordance of Cognitive and Functional Progression in Patients with Mild Cognitive Impairment in the United States: A Latent Class Analysis.
    Mouchet J; Betts KA; Georgieva MV; Ionescu-Ittu R; Butler LM; Teitsma X; Delmar P; Kulalert T; Zhu J; Lema N; Desai U
    J Alzheimers Dis; 2021; 82(4):1667-1682. PubMed ID: 34219723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment.
    Zawar I; Kapur J; Mattos MK; Aldridge CM; Manning C; Quigg M
    Neurology; 2024 Sep; 103(6):e209820. PubMed ID: 39173101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sum of boxes of the clinical dementia rating scale highly predicts conversion or reversion in predementia stages.
    Tzeng RC; Yang YW; Hsu KC; Chang HT; Chiu PY
    Front Aging Neurosci; 2022; 14():1021792. PubMed ID: 36212036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database.
    O'Bryant SE; Lacritz LH; Hall J; Waring SC; Chan W; Khodr ZG; Massman PJ; Hobson V; Cullum CM
    Arch Neurol; 2010 Jun; 67(6):746-9. PubMed ID: 20558394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operational Determination of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using Sum of Boxes of the Clinical Dementia Rating Scale.
    Yang YW; Hsu KC; Wei CY; Tzeng RC; Chiu PY
    Front Aging Neurosci; 2021; 13():705782. PubMed ID: 34557083
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
    Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the time to clinically worsening in mild cognitive impairment patients and its utility in clinical trial design by modeling a longitudinal clinical dementia rating sum of boxes from the ADNI database.
    Ito K; Hutmacher MM
    J Alzheimers Dis; 2014; 40(4):967-79. PubMed ID: 24531162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia.
    Han JY; Besser LM; Xiong C; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2019; 33(2):87-94. PubMed ID: 30633043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Informant characteristics are associated with the Clinical Dementia Rating Sum of Boxes scores in the Alzheimer's Disease patients participating in the National Alzheimer's Coordinating Center Uniform Data Set.
    Vargas-Gonzalez JC; Chadha AS; Castro-Aldrete L; Ferretti MT; Tartaglia C
    Res Sq; 2024 Mar; ():. PubMed ID: 38559129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal associations between treated and untreated hearing loss and mild behavioral impairment in older adults without dementia.
    Gosselin P; Guan DX; Smith EE; Ismail Z
    Alzheimers Dement (N Y); 2023; 9(4):e12424. PubMed ID: 37818228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
    Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
    Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    Xiong LY; Ouk M; Wu CY; Rabin JS; Lanctôt KL; Herrmann N; Black SE; Edwards JD; Swardfager W
    Alzheimers Res Ther; 2021 Sep; 13(1):147. PubMed ID: 34479635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort.
    Jiang F; Mishra SR; Shrestha N; Ozaki A; Virani SS; Bright T; Kuper H; Zhou C; Zhu D
    Lancet Public Health; 2023 May; 8(5):e329-e338. PubMed ID: 37062296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.